T1 Energy Dives 12% As Culper Research Takes A Short Position Saying Company Is A ‘Failed EV Battery SPAC’
Culper Research said it has little faith in T1’s management, nor the company’s disclosures and financial reporting and said that shares are headed far lower.
Stocktwits·1mo ago
More News
FLYX Stock Surged Over 130% Today — What’s The SpaceX Connection?
Private jet operator flyExclusive announced an authorized dealership agreement with SpaceX’s Starlink on Thursday.
Stocktwits·2mo ago
Olaplex Shares Rally On Potential Takeover Offer From Germany’s Henkel
The deal could come together within weeks or the talks could not materialise in a deal at all, Bloomberg reported.
Stocktwits·2mo ago
Rumble Rallies After Unveiling Tether-Powered Crypto Wallet – Retail Expects Stock To Surpass The $10 Mark
The wallet, built with Tether’s Wallet Development Kit, currently supports Bitcoin, Tether (USDT), and Tether Gold (XAUt).
Stocktwits·2mo ago
Zeta Global Shares Rose After It Deepens Collaboration with OpenAI
Stocktwits·2mo ago
Tonix Pharmaceuticals To Meet With FDA In 2026 To Advance Experimental Lyme Disease Prevention Drug
The company also announced the pricing of a $20 million registered direct offering.
Stocktwits·2mo ago
Why Is UUUU Stock Rising Today?
The company said that its finished uranium production, mined uranium ore production, and uranium concentrate sales for FY 2025 exceeded previously announced guidance.
Stocktwits·2mo ago
BlackSky Technology Is The Latest Space Stock To Grab Investor Attention — Jefferies Expects Sales To Double In A Few Years
Jefferies initiated BlackSky coverage with a ‘Buy’ rating and a $23 price target.
Stocktwits·2mo ago
Compass Diversified Stock Plunges On ‘Most Significant Loss’ After Fraud Forces Removal Of Three Years Of Financials
The company has removed financial information for the years 2022 to 2024 from its website, citing non-reliance.
Stocktwits·3mo ago
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio
With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications.